STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Tough-to-Treat bile duct cancers
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (FOLFOX) can shrink tumors or help people with advanced bile duct or gallbladder cancers live longer. About 66 adults whose cancers have a specific genetic change (MAPK pathway mutation) and ha…
Matched conditions: STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New drug shows promise for tough bile duct cancer
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 15 people with advanced bile duct cancer that has spread or come back. The drug works like a smart bomb, attaching to a protein on cancer cells to deliver a toxic payload and kill them. The main goal is to see how many patie…
Matched conditions: STAGE IV HILAR CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC